Tom Shea

Tom is the founding CEO of Meitheal since its inception in 2017. In addition, Tom is also the founding President of Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was established in April 2020. Prior to joining Meitheal and Xentria, Tom was Vice President of Global Alliance Management for Sagent Pharmaceuticals and was responsible for global partnerships, supply chain, and product development. Before his work at Sagent, Tom held various roles at APP, now Fresenius Kabi North America, in Commercial Operations and Business Development, focusing on Portfolio Management and National Accounts.

Tom started his pharmaceutical career as a Sales Rep at Fougera, now Sandoz. During his tenure at Fougera, he held positions of increasing responsibilities eventually attaining the position of National Sales Manager. Tom earned an M.B.A. from Notre Dame University and a B.A. in Philosophy from Marquette University.